AYTU

Aytu Biopharma INC

+$848.2K

Net Activity

Institutions Holding

36

Popularity Rank

#6804

Avg Weight

0.05%

Total Value

$10.7M

Ownership Trend

36 institutions currently hold AYTU, with 13 net buyers and 11 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

11

Net Buying Institutions

13

Key Holders

View all 36 holding institutions

Quarterly Activity

Recent Activity

+$2.7M

Total Buy Value

$2.5M

Total Sell Value

New buy4
Trim5
Add9
Sold out6

13

Net Buyers

11

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AYTU BIOPHARMA INC (AYTU)?
Major stakeholders currently include Nantahala Capital Management, LLC ($3.0M), Stonepine Capital Management, LLC ($2.2M), AWM Investment Company, Inc. ($1.7M). Based on the latest 13F filings, there are a total of 36 tracked investment funds and institutions maintaining positions in AYTU.
What is the overall institutional sentiment toward AYTU recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $848.2K, driven by 13 managers accumulating shares while 11 reduced their exposure.
Which institutions have been selling or reducing their AYTU positions?
In the latest period, 5 funds trimmed their holdings, and 6 managers completely exited their positions. The aggregate reported sell value was $2.5M.
Are there any notable investors adding AYTU to their portfolios?
Yes, buying activity remains notable. 4 institutions opened new positions in {ticker}, and 9 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.7M.

Related Stocks